These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11439975)

  • 21. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
    Lethagen S; Isaksson C; Schaedel C; Holmberg L
    Thromb Haemost; 2002 Sep; 88(3):421-6. PubMed ID: 12353070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Mazurier C; Meyer D
    Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
    [No Abstract]   [Full Text] [Related]  

  • 27. The von Willebrand syndrome.
    Bloom AL
    Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
    [No Abstract]   [Full Text] [Related]  

  • 28. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G; Giacomelli SH; Jacobi P; Obser T; Budde U; Rodeghiero F; Haberichter SL; Schneppenheim R
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene.
    Gaucher C; Jorieux S; Mercier B; Oufkir D; Mazurier C
    Blood; 1991 May; 77(9):1937-41. PubMed ID: 2018834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease.
    Donnér M; Andersson AM; Kristoffersson AC; Nilsson IM; Dahlbäck B; Holmberg L
    Eur J Haematol; 1991 Nov; 47(5):342-5. PubMed ID: 1761120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.
    Allen S; Abuzenadah AM; Blagg JL; Hinks J; Nesbitt IM; Goodeve AC; Gursel T; Ingerslev J; Peake IR; Daly ME
    Blood; 2000 Mar; 95(6):2000-7. PubMed ID: 10706867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
    Federici AB; Mannucci PM; Marco P
    Haemophilia; 2008 Jan; 14(1):133-9. PubMed ID: 17941830
    [No Abstract]   [Full Text] [Related]  

  • 35. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
    Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
    Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12.3-kb Duplication Within the
    Lehner S; Ekhlasi-Hundrieser M; Detering C; Allerkamp H; Pfarrer C; von Depka Prondzinski M
    G3 (Bethesda); 2018 Feb; 8(2):577-585. PubMed ID: 29208651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular biology of von Willebrand disease.
    Keeney S; Cumming AM
    Clin Lab Haematol; 2001 Aug; 23(4):209-30. PubMed ID: 11683782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
    Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
    Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy and delivery in patients with homozygous or heterozygous R854Q type 2N von Willebrand disease.
    Castaman G; Bertoncello K; Bernardi M; Rodeghiero F
    J Thromb Haemost; 2005 Feb; 3(2):391-2. PubMed ID: 15670054
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular basis of von Willebrand disease and its clinical implications.
    Haematologica; 2004 Sep; 89(9):1036. PubMed ID: 15377463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.